Christiansen C - Search Results

1

A computer-based measure of irregularity in vertebral alignment is a BMD-independent predictor of fracture risk in postmenopausal women.

Pettersen PC, de Bruijne M, Chen J, He Q, Christiansen C, Tankó LB. Pettersen PC, et al. Among authors: christiansen c. Osteoporos Int. 2007 Nov;18(11):1525-30. doi: 10.1007/s00198-007-0388-y. Epub 2007 May 22. Osteoporos Int. 2007. PMID: 17516021

2

Does serum cholesterol contribute to vertebral bone loss in postmenopausal women?

Tankó LB, Bagger YZ, Nielsen SB, Christiansen C. Tankó LB, et al. Among authors: christiansen c. Bone. 2003 Jan;32(1):8-14. doi: 10.1016/s8756-3282(02)00918-3. Bone. 2003. PMID: 12584030

3

Radiographic measure of aorta calcification is a site-specific predictor of bone loss and fracture risk at the hip.

Bagger YZ, Tankó LB, Alexandersen P, Qin G, Christiansen C; Prospective Epidemiological Risk Factors Study Group. Bagger YZ, et al. Among authors: christiansen c. J Intern Med. 2006 Jun;259(6):598-605. doi: 10.1111/j.1365-2796.2006.01640.x. J Intern Med. 2006. PMID: 16704561 Free article.

4

Links between cardiovascular disease and osteoporosis in postmenopausal women: serum lipids or atherosclerosis per se?

Bagger YZ, Rasmussen HB, Alexandersen P, Werge T, Christiansen C, Tankó LB; PERF study group. Bagger YZ, et al. Among authors: christiansen c. Osteoporos Int. 2007 Apr;18(4):505-12. doi: 10.1007/s00198-006-0255-2. Epub 2006 Nov 16. Osteoporos Int. 2007. PMID: 17109061 Free PMC article.

5

Vertebral fracture risk (VFR) score for fracture prediction in postmenopausal women.

Lillholm M, Ghosh A, Pettersen PC, de Bruijne M, Dam EB, Karsdal MA, Christiansen C, Genant HK, Nielsen M. Lillholm M, et al. Among authors: christiansen c. Osteoporos Int. 2011 Jul;22(7):2119-28. doi: 10.1007/s00198-010-1436-6. Epub 2010 Nov 11. Osteoporos Int. 2011. PMID: 21069295

6

The efficacy of 48-week oral ibandronate treatment in postmenopausal osteoporosis when taken 30 versus 60 minutes before breakfast.

Tankó LB, McClung MR, Schimmer RC, Mahoney P, Christiansen C. Tankó LB, et al. Among authors: christiansen c. Bone. 2003 Apr;32(4):421-6. doi: 10.1016/s8756-3282(03)00033-4. Bone. 2003. PMID: 12689686 Clinical Trial.

7

Dose dependent effects on bone resorption and formation of intermittently administered intravenous ibandronate.

Christiansen C, Tankó LB, Warming L, Moelgaard A, Christgau S, Qvist P, Baumann M, Wieczorek L, Hoyle N. Christiansen C, et al. Osteoporos Int. 2003 Jul;14(7):609-13. doi: 10.1007/s00198-003-1409-0. Epub 2003 Jun 26. Osteoporos Int. 2003. PMID: 12830369 Clinical Trial.

8

Oral weekly ibandronate prevents bone loss in postmenopausal women.

Tankó LB, Felsenberg D, Czerwiński E, Burdeska A, Jonkanski I, Hughes C, Christiansen C; Oral Ibandronate Group. Tankó LB, et al. Among authors: christiansen c. J Intern Med. 2003 Aug;254(2):159-67. doi: 10.1046/j.1365-2796.2003.01174.x. J Intern Med. 2003. PMID: 12859697 Free article. Clinical Trial.

9

Low bone mineral density in the hip as a marker of advanced atherosclerosis in elderly women.

Tankò LB, Bagger YZ, Christiansen C. Tankò LB, et al. Among authors: christiansen c. Calcif Tissue Int. 2003 Jul;73(1):15-20. doi: 10.1007/s00223-002-2070-x. Calcif Tissue Int. 2003. PMID: 14506949

10

Effects of 17beta-oestradiol plus different doses of drospirenone on adipose tissue, adiponectin and atherogenic metabolites in postmenopausal women.

Tankó LB, Christiansen C. Tankó LB, et al. Among authors: christiansen c. J Intern Med. 2005 Dec;258(6):544-53. doi: 10.1111/j.1365-2796.2005.01571.x. J Intern Med. 2005. PMID: 16313478 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,608 results

Search Page

Filters